Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell

RNA

Volumn 15, Issue 8, 2009, Pages 1443-1461

  Sotiropoulou, Georgia ^a   Pampalakis, Georgios ^a   Lianidou, Evi ^b   Mourelatos, Zissimos ^c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer cell circuit; miRNAs; Molecular switch; Oncomirs; Tumor suppressor miRNAs

Indexed keywords

MICRORNA;

ANGIOGENESIS; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; COLORECTAL CANCER; DEREGULATION; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; GENETIC POLYMORPHISM; HUMAN; INTEGRATED CIRCUIT; KIDNEY CANCER; MESENCHYME CELL; METASTASIS; MUTATION; NONHUMAN; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVIEW; RNA EDITING; RNA SYNTHESIS; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION; TUMOR VIRUS; UPREGULATION; UTERINE CERVIX CANCER;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MODELS, BIOLOGICAL; MUTATION; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENIC VIRUSES; RNA EDITING; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TELOMERE;

EID: 67651002343     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.1534709     Document Type: Review

References (216)

1. Adams BD, Furneaux H, White B. 2007. The micro-RNA miR-206 targets the human estrogen receptor-α, and represses ERα mRNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 1132-1147.
2. Akao Y, Nakagawa Y, Kitabe Y, Kinoshita T, Naoe T. 2007. Down-regulation of miR-143 and miR-145 in B-cell malignancies. Cancer Sci 12: 1914-1920.
3. Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T, Margalit H. 2005. Clustering and conservation patterns of human microRNAs. Nucleic Acids Res 33: 2697-2706.
4. Alvarez-Garcia I, Miska EA. 2005. MicroRNA functions in animal development and human disease. Development 132: 4653-4662.
5. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally down-regulates tumor suppressor Pdcd4 and stimulates invasion, intravasation, and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
6. Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y, Polymi RTS. 2007. Database: Linking polymorphisms in micro-RNA target sites with complex traits. Nucleic Acids Res 35: D51-D54.
7. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
8. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jäker C, Höck J, Meister G, Grässer FA. 2008. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666-675.
9. Bass BL. 2002. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71: 817-846.
10. Benetti R, Gonzalo S, Jaco I, Muñoz P, Gonzalez S, Schoeftner S, Murchison E, Andl T, Chen T, Klatt P, et al. 2008. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 15: 268-279.
11. Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC. 2007. Mammalian mirtron genes. Mol Cell 28: 328-336.
12. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. 2001. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366.
13. Blackburn EH. 2001. Switching and signalling at the telomere. Cell 1067: 661-673.
14. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM. 2007. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 297: 1901-1908.
15. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, et al. 2007. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307.
16. Borchert GM, Lanier W, Davidson BL. 2006. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 13: 1097-1101.
17. Borgoño CA, Diamandis EP. 2004. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4: 876-890.
18. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. 2005. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204: 280-285.
19. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sültmann H, Lyko F. 2007. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419-1423.
20. Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, Santos J, Calin GA, Cigudosa JC, Croce CM, Fernández-Piqueras J, Malumbres M. 2008. Genetic and epigenetic silencing of micro-RNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13: 496-506.
21. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci 102: 5570-5575.
22. Cai X, Li G, Laimins LA, Cullen BR. 2006. Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication. J Virol 80: 10890-10893.
23. Calin GA, Croce CM. 2006. MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
24. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al. 2002. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci 99: 15524-15529.
25. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, et al. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancer. Proc Natl Acad Sci 101: 2999-3004.
26. Calin G, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al. 2005. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
27. Chang TC, Wentzel EA, Kent AO, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, et al. 2007. Transactivation of miR-43a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
28. Chen Y, Gorski DH. 2008. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111: 1217-1226.
29. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436: 740-744.
30. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, et al. 2008. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases nonsmall cell lung cancer risk. Cancer Res 68: 8535-8540.
31. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R. 2006. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinomas. Am J Pathol 169: 1812-1820.
32. Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. 2007. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 67: 2345-2350.
33. Cho WC. 2007. OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
34. Chow TF, Chow M, Earle T, El-Said H, Diamandis EP, Yousef GM. 2008. Kallikreins as microRNA targets: An in silico and experimental-based analysis. Biol Chem 389: 731-738.
35. Christoffersen NR, Silahtaroglu A, Orom UA, Kauppineen S, Lund AH. 2007. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 13: 1172-1178.
36. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG. 2005. Extensive modulation of a set of microRNAs in primary gliobastoma. Biochem Biophys Res Commun 334: 1351-1358.
37. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et al. 2005. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci 102: 13944-13949.
38. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. 2007. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438.
39. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. 2007. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delived S-TRAIL in human gliomas. Cancer Res 67: 8994-9000.
40. Cui JW, Li YJ, Sarkar A, Brown J, Tan YH, Premyslova M, Michaud C, Iscove N, Wang GJ, Ben-David Y. 2007. Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation. Blood 100: 2631-2640.
41. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, et al. 2006. The colorectal microRNAone. Proc Natl Acad Sci 103: 3687-3692.
42. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu C-G, Volinia S, Croce CM, Schmittgen TD, et al. 2008. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 68: 5049-5058.
43. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WN, Enders GH, Mendell JT, et al. 2006. Augmentation of tumor angiogenesis by a Myc-activated micro-RNA cluster. Nat Genet 38: 1060-1065.
44. Diederich S, Haber DA. 2006. Sequence variations of microRNAs in human cancer: Alterations in predicted secondary structure do not affect processing. Cancer Res 66: 6097-6104.
45. Du T, Zamore PD. 2005. MicroPrimer: The biogenesis and function of microRNA. Development 132: 4645-4652.
46. Duan R, Pak C, Jin P. 2007. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 16: 1124-1131.
47. Ebert MS, Neilson JR, Sharp PA. 2007. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
48. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. 2005. Accumulation of miR-155 and BIC RNA in human B cell lumphomas. Proc Natl Acad Sci 102: 3627-3632.
49. Elmén J, Lindow M, Schütz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjärn M, Hansen HF, Berger U, et al. 2008. LNA-mediated microRNA silencing in nonhuman primates. Nature 452: 896-899.
50. Esquela-Kerscher A, Slack FJ. 2006. Oncomirs - MicroRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
51. Fabani MM, Gait MJ. 2008. miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA peptide conjugates. RNA 14: 336-346.
52. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci 104: 15805-15810.
53. Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, Travaglini L, Diverio D, Ammatuna E, Cimino G, Lo-Coco F, et al. 2007. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12: 457-466.
54. Fedi P, Tronick SR, Aaronson SA. 1997. Growth factors. In Cancer medicine (eds. JF Holland et al.), pp. 41-64. Williams and Wilkins, Baltimore, MD.
55. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9: 102-114.
56. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
57. Fluiter K, Frieden M, Vreijling J, Rosebohm C, De Wissel MB, Christensen SM, Koch T, Ørum H, Baas F. 2005. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotides. Chem-BioChem 6: 1104-1109.
58. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. 2008. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
59. Forman JJ, Legesse-Miller A, Coller HA. 2008. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence. Proc Natl Acad Sci 39: 14879-14884.
60. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O'Brien-Jenkins A, Katsaros D, Weber BL, et al. 2008. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7: 255-264.
61. Gottardo F, Liu CG, Ferranic M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et al. 2007. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
62. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, et al. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099.
63. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
64. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. 2005. Human RISC couples microRNA biogenesis and post-transcriptional gene silencing. Cell 123: 631-640.
65. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC. 2001. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106: 23-34.
66. Grundhoff A, Sullivan CS, Ganem D. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human g-herpesviruses. RNA 12: 733-750.
67. Guidotti LG, Chisari FV. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23-61.
68. Han L, Witmer PD, Casey E, Valle D, Sukumar S. 2007. DNA methylation regulates microRNA expression. Cancer Biol Ther 6: 1284-1288.
69. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
70. Hannon GJ, Beach D. 1994. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
71. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
72. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, et al. 2005a. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci 102: 19075-19080.
73. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, et al. 2005b. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
74. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
75. Hermeking H. 2007. p53 enters the microRNA world. Cancer Cell 12: 411-418.
76. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M, Pagano JS. 2007. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970-1978.
77. Hossain A, Kuo MT, Saunders GF. 2006. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26: 8191-8201.
78. Hua Z, Lv Q, Ye W, Wong CKA, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, et al. 2006. miRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116. doi: 10.1371/journal.pone. 0000116.
79. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al. 2008. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
80. Hutvágner G, Simard MJ. 2008. Argonaute proteins: Key players in RNA silencing. Nat Rev Mol Cell Biol 9: 22-32.
81. Hutvágner G, McLachlan J, Pasquinelli AE, Bálint E, Tuschl T, Zamore PD. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
82. Hwang H-W, Wentzel EA, Mendell JT. 2007. A hexanucleotide element directs miRNA nuclear import. Science 315: 97-100.
83. Ibarra I, Erlich Y, Muthuswamy SK, Sachidanandam R, Hanon GJ. 2007. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes & Dev 21: 3238-3243.
84. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
85. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalinin P, Taccioli C, Volinia S, Liu CG, Alder H, et al. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707.
86. Irvin-Wilson CV, Chaudhuri G. 2005. Alternative initiation and splicing in dicer gene expression in human breast cells. Breast Cancer Res 7: R563-R569.
87. Iwai N, Naraba H. 2005. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 331: 1439-1444.
88. Jiang J, Lee EJ, Gusev Y, Schmittgen TD. 2005. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403.
89. Jin P, Alisch RS, Warren ST. 2004. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 6: 1048-1053.
90. Jin WB, Wu FL, Kong D, Guo AG. 2007. HBV-encoded microRNA candidate and its target. Comput Biol Chem 31: 124-126.
91. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. 2005. RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
92. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, et al. 2005. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115.
93. Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. 2007a. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep 8: 763-769.
94. Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. 2007b. Redirection of silencing targets by adenosineto-inosine editing of miRNAs. Science 315: 1137-1140.
95. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. 2001. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes & Dev 15: 2654-2659.
96. Kim DN, Chae HS, Oh ST, Kang JH, Park CH, Park WS, Takada K, Lee JM, Lee WK, Lee SK, 2007. Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81: 1033-1036.
97. Kim VN, Han J, Siomi MC. 2009. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139.
98. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z. 2007. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129: 1141-1151.
99. Korpal M, Lee ES, Hu G, Kang Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914.
100. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs.' Nature 438: 685-689.
101. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. 2007. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101: 59-68.
102. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Danuluri R, Liu CG, Croce CM, Negrini M, et al. 2007. A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867.
103. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
104. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K. 2006. Down-regulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678.
105. Lee YS, Dutta A. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes & Dev 21: 1025-1030.
106. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 5: 843-854.
107. Lee YS, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. 2004. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060.
108. Lee DY, Deng Z, Wang CH, Yang BB. 2007a. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci 104: 20350-20355.
109. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al. 2007b. Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542.
110. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, et al. 2008. Altered microRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542.
111. Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H. 2008. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
112. Lester RD, Jo M, Montel V, Takimoto S, Gonias SL. 2007. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178: 425-436.
113. Li Z, Zhan W, Wang Z, Zhu B, He Y, Peng J, Cai S, Ma J. 2006. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 348: 229-237.
114. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J, Shim H. 2004. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64: 4302-4308.
115. Liang Z, Wu H, Reddy S, Zhu A, Wang S, Blevins D, Yoon Y, Zhang Y, Shim H. 2007. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial miRNA. Biochem Biophys Res Commun 363: 542-546.
116. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
117. Liu X, Fortin K, Mourelatos Z. 2008. MicroRNAs: Biogenesis and molecular functions. Brain Pathol 18: 113-121.
118. Lo AL, To KF, Lung RW, Hui JW, Liao G, Hayward SD. 2007. Modulation of LMP1 protein expression by EBV-encoded micro-RNAs. Proc Natl Acad Sci 104: 16164-16169.
119. Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK, Burger R, Gramatzki M, Blumert C, Bauer K, et al. 2007. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333.
120. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435: 834-848.
121. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. 2007. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310: 442-453.
122. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. 2008. Epstein-Barr virus-induced miR-155 attenuates NF-κB signaling and stabilizes latent virus persistance. J Virol 82: 10436-10443.
123. Luciano DJ, Mirsky H, Vendetti NJ, Maas S. 2004. RNA editing of a miRNA precursor. RNA 10: 1174-1177.
124. Lui WO, Pourmand N, Patterson BK, Fire A. 2007. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043.
125. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, et al. 2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67: 1424-1429.
126. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez- Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. 2008. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci 105: 13556-13561.
127. Lund E, Güttinger S, Calado A, Dahlberg JE, Kutay U. 2004. Nuclear export of microRNA precursors. Science 303: 95-98.
128. Ma L, Teruya-Feldstein J, Weiberg RA. 2007. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
129. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou E. 2008. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in nonsmall cell lung cancer by quantitative real-time RT-PCR. Clin Chem 4: 1696-1704.
130. Martin SE, Caplen NJ. 2007. Applications of RNA interference in mammalian systems. Annu Rev Genomics Hum Genet 8: 81-90.
131. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. 2006. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282: 24262-24269.
132. Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, Murata T, Biffo S, Merrick WC, Darzynkiewicz E, Pillai RS, et al. 2007. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317: 1764-1767.
133. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197.
134. Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Savan AE, Berx G, Mellon JK, Tulchinsky E. 2007. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 18: 4615-4624.
135. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T. 2006. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
136. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
137. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. 2003. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
138. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumber S. 2008. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(Kip1). J Biol Chem 283: 29897-29903.
139. Mishra PJ, Humeniuk R, Mishra PJ, Long-Sorbello GS, Banerjee D, Bertino JR. 2007. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci 14: 13513-13518.
140. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu N, et al. 2008. Down-regulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 99: 280-286.
141. Muntoni A, Redder RR. 2005. The first molecular details of ALT in human tumor cells. Hum Mol Genet 14: R191-R196.
142. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumber S, Wang B, Suster S, Jacob ST, Ghoshal K. 2008. Down-regulation of microRNA-1 (miR-1) in lung cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin induced apoptosis by miR-1. J Biol Chem 283: 33394-33405.
143. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, et al. 1995. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3. Cancer Res 55: 3003-3007.
144. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. 2004. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Methods 1: 155-161.
145. Niu QW, Lin SS, Reyes JL, Chen KC, Wu HW, Yeh SD, Chua NH. 2006. Expression of artificial microRNAs in transgenic Arabidopsis thaliana confers virus resistance. Nat Biotechnol 24: 1420-1428.
146. Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, Shi YR, Hao XS. 2007. Upregulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 26: 385-394.
147. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendrell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
148. Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. 2007. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130: 89-100.
149. Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. 2007. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67: 10782-10788.
150. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, et al. 2006. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508.
151. Peters L, Meister G. 2007. Argonaute proteins: Mediators of RNA silencing. Mol Cell 26: 611-623.
152. Petersen M, Bondensgaard K, Wengel J, Jacobsen JP. 2002. Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J Am Chem Soc 124: 5974-5982.
153. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, et al. 2008. E2F1-regulated microRNAs impair TGFβ-dependent cellcycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
154. Pfeffer S, Voinnet O. 2006. Viruses, microRNAs, and cancer. Oncogene 25: 6211-6219.
155. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, et al. 2004. Identification of virus-encoded microRNAs. Science 304: 734-736.
156. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, et al. 2005. Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
157. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz W. 2005. Inhibition of translational initiation by let-7 microRNA in human cells. Science 309: 1573-1576.
158. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. 2008. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci 105: 1608-1613.
159. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G. 2006. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071.
160. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T. 2007. MicroRNA expression profiling in prostate cancer. Cancer Res 67: 6130-6135.
161. Rand TA, Ginalski K, Grishin NV, Wang X. 2004. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc Natl Acad Sci 101: 14385-14398.
162. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach D, et al. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci 104: 12884-12889.
163. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM. 1995. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res 55: 3988-3991.
164. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
165. Reya T, Morrisson SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
166. Rivas FV, Tolia NH, Song JJ, Aragon JP, Liu J, Hannon GJ, Joshua-Tor L. 2005. Purified Argonaute2 and an siRNA form recombinant human RISC. Nat Struct Mol Biol 12: 340-349.
167. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A, et al. 2006. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684.
168. Ruby JG, Jan CH, Bartel DP. 2007. Intronic microRNA precursors that bypass Drosha processing. Nature 448: 83-86.
169. Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. 2009. p53 represses c-myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci 106: 3207-3212.
170. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R. 2007. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3: e65. doi: 10.1371/ journal.ppat.0030065.
171. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. 2007. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67: 9762-9770.
172. Scott GK, Goga A, Bhaumik D, Berger CE, Sullivan CS, Benz CC. 2007. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of microRNA miR-125a or miR-125b. J Biol Chem 282: 1479-1486.
173. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME. 2007. let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci 104: 11400-11405.
174. Sheng Y, Engström PG, Lenhard B. 2007. Mammalian microRNA prediction through a support vector machine model of sequence and structure. PLoS One 2: e946. doi: 10.1371/journal.pone. 0000946.
175. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AS, Antonarakis SE. 2007. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81: 405-413.
176. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW. 2007. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci 104: 19983-19988.
177. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21 mediated tumor growth. Oncogene 26: 2799-2803.
178. Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG, Zavolan M, Svoboda P, Filipowicz W. 2008. MicroRNA control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells. Nat Struct Mol Biol 15: 259-267.
179. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L. 2004. Crystal structure of argonaute and its implications for RISC slicer activity. Science 305: 1434-1437.
180. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, Norstedt G, Alenius H, Homey B, Scheynius A, et al. 2007. MicroRNAs: Novel regulators involved in the pathogenesis of psoriasis? PLoS One 2: e670. doi: 10.1371/journal.pone. 0000610.
181. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
182. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, Kita T, Satoh N, Shimatsu A, Hasegawa K. 2008. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun 376: 728-732.
183. Talotta F, Cimmino A, Matarazzo MR, Casalino L, De Vita G, D'Esposito M, Di Lauro R, Verde P. 2009. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28: 73-84.
184. Tang X, Tang G, Ozcan S. 2008. Role of microRNAs in diabetes. Biochim Biophys Acta 1779: 697-701.
185. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H. 2007. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593.
186. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, William GL, Massagué J. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
187. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. 2007. Tumor-suppressor miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci 104: 15472-15477.
188. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
189. Thuault S, Valcourt U, Petersen M, Manfioletti G, Heldin CH, Moustakas A. 2006. Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 174: 175-183.
190. Tsonis PA, Call MK, Grogg MW, Sartor MA, Taylor RR, Forge A, Fyffe R, Goldenberg R, Cowper-Sal-lari R, Tomlinson CR. 2007. MicroRNAs and regeneration: Let-7 members in lens and inner ear hair cell regeneration of the adult newt. Biochem Biophys Res Commun 362: 940-945.
191. Válóczi A, Hornyik C, Varga N, Burgyán J, Kauppinen S, Havelda Z. 2004. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res 32: e175. doi: 10.1093/nar/gnh171.
192. Vasudevan S, Tong Y, Steitz JA. 2007. Switching form repression to activation: MicroRNAs can up-regulate translation. Science 318: 1931-1934.
193. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci 103: 2257-2261.
194. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, et al. 2006. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
195. Wang CL, Wang BB, Bartha G, Li L, Channa N, Klinger M, Killeen N, Wabl M. 2006. Activation of an oncogenic microRNA cistron by provirus integration. Proc Natl Acad Sci 103: 18680-18684.
196. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. 2008a. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
197. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT. 2008b. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 28: 1213-1223.
198. Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA. 2003. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 3: 219-231.
199. Weidhaas JB, Badar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E, Slack EJ. 2007. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111-11116.
200. Welch C, Chen Y, Stalling RL. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
201. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. 2008. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592.
202. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B. 2007. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052.
203. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
204. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 104: 927-939.
205. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. 2005. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem 280: 9330-9335.
206. Yi R, Qin Y, Macara IG, Cullen BR. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Dev 17: 3011-3016.
207. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, et al. 2007. let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
208. Zamore PD, Haley B. 2005. Ribo-gnome: The big world of small RNAs. Science 309: 1519-1524.
209. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Prot-Siqueira R, Falcão RP, Zago MA, Silva WA Jr. 2007. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40: 1435-1440.
210. Zhang B, Pan X, Anderson TA. 2006a. MicroRNA: A new player in stem cells. J Cell Physiol 209: 266-269.
211. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, et al. 2006b. Micro-RNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci 103: 9136-9141.
212. Zhang B, Pan X, Cobb GP, Anderson TA. 2007a. MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
213. Zhang HH, Wang XJ, Li GX, Yang F, Yang NM. 2007b. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol 13: 2883-2888.
214. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. 2008. MicroRNA-221/222 negatively regulates ERα and associates with tamoxifen resistance in breast cancer. J Biol Chem 283: 31079-31086.
215. Zhu S, Si ML, Wu H, Mo YY. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.
216. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.